Saturday, 26 November 2022

 

 

LATEST NEWS Advocate General office celebrates Constitution Day Union Minister Dr Jitendra Singh says, under PM Modi, giant strides are being taken in the field of IT and new age technologies for better delivery of governance to citizens Maruti Suzuki & LPU Collaborated to host EFFICYCLE-2022 Competition at LPU Campus Chief Secretary R.D. Dhiman chairs high level meeting to review winter preparedness District-Level Constitution Day Function Held At Bachat Bhawan Atal Dulloo reviews working of Farmer Producer Organizations in Jammu Constitution Day : Judicial Academy organizes workshop, special skill enhancement training for Civil Judges of Jammu Province Week-long Shehri Jan Abhiyan from Nov 28, two-day MTMP-2.0 from Dec 5 : Dheeraj Gupta ACS Atal Dulloo visits Mega Fruit Plant Nursery, Chakroi, R S Pura Chief Secretary Dr. Arun Kumar Mehta reads Preamble at Constitution Day celebration at Reasi Lt Governor Manoj Sinha Inaugurates Constitution Day Celebrations Amrit Maan Unveils The Title & Poster Of Debut EP ‘Xpensive’ Challa Song Review: Ninja Gives Impactful Vocal In Upcoming Punjabi Crime Thriller Snowman 'BB 16': Kajol, Revathy join Salman Khan 'Weekend Ka Vaar' NASA's Mars helicopter makes a short yet significant flight Veteran films, theatre and television actor Vikram Gokhale passes away at 77 Vivek Oberoi on his 'Dharavi Bank' role : Dignity of men in uniform is important Australia snatch 5-4 win against India in first match of hockey series Patriarchal Clash Between These Bollywood Celebrities Sheikh Zayed Festival intensifies preparations for UAE’s 51st National Day celebrations Drunk on power, Asaduddin Owaisi on Amit Shah's Gujarat riots remark

 

AIIMS to begin Covid vaccine human trial from next week

Web Admin

Web Admin

5 Dariya News

New Delhi , 18 Jul 2020

In a major development, AIIMS Delhi will begin human trials of India's first indigenous Covid-19 vaccine, Covaxin, from next week on 100 healthy volunteers aged between 18 and 55.The volunteers will be kept under observation for a period of nearly 150 days. Covaxin is developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV).According to Bharat Biotech, The Phase 1 clinical trial for Covaxin has been initiated across the country from July 15 onwards, and this is a randomised, double-blind, placebo-controlled clinical trial on 375 volunteers across the country.Speaking to IANS, Sanjay Rai, Professor of Community Medicine and Principal Investigator of Covid-19 vaccine trial at AIIMS, said, "We will begin human trials of India's first indigenous vaccine, Covaxin, on 100 healthy volunteers aged between 18 and 55 years. We will ensure that none of the volunteers have any comorbidities. AIIMS will conduct trials on 100 volunteers out of a total of 375 persons."AIIMS has also set up a dedicated email and phone number for the volunteers to register themselves for this project. The volunteers will have to undergo tests, which include Covid-19 test and also tests for other comorbidities. If found healthy, they will be administered the vaccine.

According to a senior official, recently the ethics committee has given a go-ahead for human trials for the vaccine, and AIIMS will begin registering volunteers as per the procedure."After administering the vaccine, we will follow up with the volunteers through phone calls. They will be kept under observation for nearly 150 days," added Rai. Volunteers willing to register for human trials can email at [email protected] Friday, Haryana Health Minister Anil Vij had said that human trial of a vaccine against novel coronavirus has begun at the Post Graduate Institute of Medical Sciences in Rohtak. "Three subjects have enrolled for the trial and tolerated the vaccine very well. There were no adverse effects," he said.The SARS-CoV-2 strain was isolated in NIV, Pune, and transferred to Bharat Biotech. The indigenous, inactivated vaccine was developed and manufactured in Bharat Biotech's BSL-3A (Bio-Safety Level 3) High Containment facility located in Genome Valley, Hyderabad.The Drug Controller General of India, Central Drugs Standard Control Organisation (CDSCO), and the Ministry of Health & Family Welfare granted permission to initiate Phase-I and II human clinical trials after the company submitted results generated from pre-clinical studies, demonstrating safety and immune response.

 

Tags: Coronavirus , COVID 19 , Novel Coronavirus , India Fights Corona , Indian Council of Medical Research , ICMR , Bharat Biotech , National Institute of Virology , NIV , AIIMS , All India Institute Of Medical Sciences

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2022 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD